1455 Adams Drive
Quantapore Inc. is developing a novel, nanopore based nucleic acid sequencing technology. Unlike other nanopore approaches, Quantapore utilizes an optical read out which results in lower cost and higher throughput compared to electrical data acquisition.
Our proprietary sequencing technology will also eliminate other bottlenecks associated with today’s sequencing technologies, namely laborious sample preparation and short read length.
CEO: Martin Huber, Ph.D.
President: Sascha C. Dennstedt, MD, MSc
Please click here for Quantapore job opportunities.